Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Health Investment News
  • ChrysCapital buys 27...

ChrysCapital buys 27 percent stake in Corona Remedies for Rs 670 crore

Medical Dialogues TeamWritten by Medical Dialogues Team Published On 2021-04-07T17:29:00+05:30  |  Updated On 7 April 2021 11:59 AM GMT
ChrysCapital buys 27 percent stake in Corona Remedies for Rs 670 crore

New Delhi: ChrysCapital, an Indian private equity firm, has bought a 27 percent stake in Gujarat-based drug maker Corona Remedies through a secondary transaction for Rs 670 crore.A Malaysian private equity firm Creador struck a deal with ChrysCapital in which it sold its minority stake in Ahmedabad-based firm Corona Remedies to a local private equity firm, ChrysCapital.With this deal, the...

New Delhi: ChrysCapital, an Indian private equity firm, has bought a 27 percent stake in Gujarat-based drug maker Corona Remedies through a secondary transaction for Rs 670 crore.

A Malaysian private equity firm Creador struck a deal with ChrysCapital in which it sold its minority stake in Ahmedabad-based firm Corona Remedies to a local private equity firm, ChrysCapital.

With this deal, the private equity firm Creador has made its full exit from Corona Remedies with a 4.0x return and an internal rate of return of 35% in INR terms (or 3.7x return and an IRR of 32% in USD terms).

Also Read:Piramal To Acquire Hemmo Pharma For Rs 775 Crore

As per the recent media report in The Economic Times, Chrys Cap has signed a deal with Creador and the promoter to acquire the minority stake in Corona Remedies for Rs 670 crore and the deal values Corona Remedies at Rs 2300 crore.

In July 2016, Creador III had invested Rs 1,180 million ($17.6 million) for a minority stake in Corona.

Corona Remedies is a company in India's domestic formulations market, founded in 2004 by Dr Kirtibhai Mehta and his two sons, Nirav and Ankur Mehta. It is a pharma manufacturer and distributor whose product line contains formulations for gynaecology, cardio diabetes, nutraceuticals, anti-infectives, orthopaedics, and paediatrics, among other therapeutic areas. Corona's revenue expanded by 2.6x and EBITDA increased by over 8x during Creador's investment period.

ET adds that the founder and CEO of Creador Brahmal Vasudevan stated that Creador is pleased to have played a vital role in supporting Corona Remedies during this exciting growth phase, including being an active investor and providing strategic advice to support its growth plans.

According to a media report in Deal Streat Asia, ChrysCapital director Kshitij Sheth commented on the investment, saying that the domestic pharmaceutical market is a big, attractive, and resilient market with a healthy outlook. Corona is one of the fastest-growing pharmaceutical companies in India, with an emphasis on exciting therapeutic areas such as cardiology, diabetes, and gynaecology.

Concerning the same, Corona Remedies' founder-director, Nirav Mehta, mentioned that they intend to use their strong management skills and ChrysCapital's comprehensive sectoral expertise to propel the business to new heights. Further, he added that they're all working together to generate value for all parties involved.

Also Read: AstraZeneca Sold Its 7.7 Percent Stake In Moderna For More Than $1 Billion: Report
ChrysCapital Creador Private equity firm Corona remedies 
Source : with inputs
Medical Dialogues Team
Medical Dialogues Team

    Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok